Artiva Biotherapeutics In... (ARTV)
7.06
0.53 (8.12%)
At close: Jan 21, 2025, 3:59 PM
7.07
0.14%
After-hours Jan 21, 2025, 04:00 PM EST
Company Description
No Company description available at the moment.
Artiva Biotherapeutics Inc. Common Stock
| Country | n/a |
| IPO Date | n/a |
| Industry | n/a |
| Sector | n/a |
| Employees | 82 |
| CEO | Dr. Fred Aslan M.D. |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | n/a |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Fred Aslan M.D. | President, Chief Executive Officer & Director |
| Jennifer Kinsbruner Bush Esq., J.D. | Executive Vice President, Chief Operating Officer, Chief Legal Officer, Corporate Secretary & Compliance Officer |
| Neha Krishnamohan | Chief Financial Officer & Executive Vice President of Corporate Development |
| Christopher P. Horan | Chief Technical Operations Officer |
| Dr. David Moriarty Ph.D. | Senior Vice President of Clinical Operations |
| Dr. Heather Raymon Ph.D. | Senior Vice President of Research & Early Development |
| Dr. Peter Flynn Ph.D. | Co-Founder & Strategic Advisor |
| Dr. Thorsten Graef M.D., Ph.D. | Chief Medical Officer |